Dr Mark Crowther, chair of the Department of Medicine at McMaster University and past president of the Anticoagulation Forum, offers an expert overview of our current understanding of thrombosis and anticoagulation in patients with COVID-19.
Dr R. Phillip Dellinger, senior critical care attending at Cooper University Health Care, past president of the Society of Critical Care Medicine, and lead author of sepsis guidelines, discusses ICU management of COVID-19 patients based on a New Jersey example.
Dr Edward Mills, associate professor in the Department of Health Research Methods, Evidence, and Impact, clinical trials advisor at the Bill & Melinda Gates Foundation, and senior principal scientist at Cytel, clarifies the concept of platform trials and their significance during the pandemic.
Dr Jean-Louis Vincent, professor of intensive care medicine at Université libre de Bruxelles and past president of the World Federation of Societies of Intensive and Critical Care Medicine, talks about the current situation in Belgium and effectiveness of available treatments.
Dr R. Phillip Dellinger, senior critical care attending at Cooper University Health Care, past president of the Society of Critical Care Medicine, and lead author of sepsis guidelines, talks about some of the striking features of COVID-19 and current patterns of practice.
Dr Miłosz Parczewski, head of the Polish Scientific AIDS Society, reviews some hypotheses about SARS-CoV-2 and takes a closer look at the potential drugs under investigation.
Dr Gordon Guyatt, distinguished professor in the Department of Health Research Methods, Evidence, and Impact at McMaster University and one of the founders of EBM, discusses the rationale behind making treatment decisions in patients with COVID-19.
Dr Jean-Louis Vincent, professor of intensive care medicine at Université libre de Bruxelles and past president of the World Federation of Societies of Intensive and Critical Care Medicine, discusses the currently available treatment options for COVID-19.
Dr Jean-Louis Vincent, professor of intensive care medicine at Université libre de Bruxelles and past president of the World Federation of Societies of Intensive and Critical Care Medicine, discusses the currently available treatment options for COVID-19.
Dr Bram Rochwerg, assistant professor in the Division of Critical Care and medical lead in the intensive care unit at the Juravinski Hospital, discusses the currently available treatment options for COVID-19 and their use outside of clinical trials.
English
Polski
Español
українська